But this research is not necessarily led by researchers with a primary interest and background in this field. As the immunomodulatory effects of more established cancer therapies (e.g. radiotherapy ...
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
Johnson & Johnson announces Carvykti demonstrated significantly higher rates of MRD negativity compared to standard therapies in CARTITUDE-4 study: San Diego Wednesday, December 1 ...
Dr Navya Verma Cancer is one of the most dreaded diseases of the 21th century and spreading further with continuance and increasing incidence. It is the third leading cause of death worldwide. It is a ...